SUSEELA PINNAMANENI's Insider Trades & SAST Disclosures
SUSEELA PINNAMANENI's most recent trade in Natco Pharma Ltd. was a Acquisition of 246 Equity Shares done at an average price of Rs. 895.5 . Disclosure was reported to the exchange on Aug. 25, 2021 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
No reported SAST transactions available for SUSEELA PINNAMANENI in the Trendlyne database.
| Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Natco Pharma | Suseela Pinnamaneni | Employees Immediate Relative | Acquisition | 25 Aug 2021 | 246 | 9,000 (0%) | 0.00% | 895.5 | 220,285 | 24 Aug 2021 24 Aug 2021 |
Insider Trading | Equity Shares | Market Purchase |
| Natco Pharma | SUSEELA PINNAMANENI | Immediate Relative | Acquisition | 19 Feb 2021 | 7,350 | 8,754 (0%) | 0.00% | 0 | 0 | 18 Feb 2021 18 Feb 2021 |
Insider Trading | Equity Shares | Inter-se Transfer |
Acquisition (Buy): Purchase of shares
Disposal (Sell): Sale of shares
Pledge: Shares being used by promoters as collateral for loans. Usually a negative signal.
Revoke: When shares are released from a pledge. Usually a positive signal.
Invoke: When pledged shares are invoked by companies/banks who have provided the collateral, which may result in acquisition of stake in the company. Usually a negative signal.
Security Type: Share/ Warrants / Convertible Debentures
Kind of transaction Mode: Public rights/ preferential offer / off market / inter-se transfer/ Market Sale
Data as reported to BSE and NSE
Insider trading data is from Disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015.